Trial · NCT07120971
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of participants who tolerate metformin | 14 days after administration of the first dose of metformin | Number of subjects who receive enteral doses of metformin and complete the study days without an adverse event while continuing enteral feedings |
| Primary | Number of participants with treatment-related adverse events | 14 days after administration of the first dose of metformin | Number of participants who develop hypoglycemia defined as blood glucose value \<50 |
| Primary | Number of participants with treatment-related metabolic acidosis | 14 days after administration of the first dose of metformin | Number of subjects who develop lactic acid levels \> 5mmol/L |
| Primary | Number of subjects with treatment-related feeding problems | 14 days after administration of the first dose of metformin | Number of subjects who require a decrease in enteral feeding volume by \>50% from baseline |
| Primary | Number of subjects who require dose adjustments of metformin | 14 days after administration of the first dose of metformin | Number of subjects who need decreases in dose or discontinuation of metformin due to hepatic or renal dysfunction |
| Primary | Number of subjects with respiratory deterioration | 14 days after administration of the first dose of metformin | Number of subjects who develop pneumonia and increases in oxygen concentration and ventilator support during the study |
| Primary | Number of subjects who complete pharmacokinetic evaluation of metformin | 14 days after administration of the first dose of metformin | Number of subjects who have at least one metformin concentration in blood measured at 1, 4 and 12 hours after an enteric dose |
| Primary | Pharmacokinetic analysis of metformin | 14 days after administration of the first dose of metformin | Area under the curve of Plasma Concentration Versus Time (AUC) of metformin over a time frame of 1, 4 and 12 hours after an enteric dose of metformin. |
| Primary | Number of subjects who complete the treatment protocol | 14 days after administration of the first dose of metformin | Number of subjects who complete the study doses of enteric metformin |
| Secondary | Incidence of bronchopulmonary dysplasia | 14 days after administration of the first dose of metformin | Number of subjects who are diagnosed with bronchopulmonary dysplasia |
| Secondary | Incidence of necrotizing enterocolitis | 14 days after administration of the first dose of metformin | Number of subjects who are diagnosed with necrotizing enterocolitis |
| Secondary | Incidence of retinopathy of prematurity | 14 days after administration of the first dose of metformin | Number of subjects who are diagnosed with retinopathy of prematurity |
| Secondary | Incidence of intraventricular hemorrhage | 14 days after administration of the first dose of metformin | Number of subjects who are diagnosed with intraventricular hemorrhage |
| Secondary | Incidence of patent ductus arteriosus | 14 days after administration of the first dose of metformin | Number of subjects who are diagnosed with patent ductus arteriosus |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07120971/registered